Tylenol-maker shares hit after report RFK Jr will suggest autism link

Date:

Natalie ShermanBBC News, New York

Anadolu via Getty Images A person purchases medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.Anadolu via Getty Images

Tylenol-maker Kenvue has said its popular pain reliever is safe, as shares in the firm dropped sharply after a report that US Health Secretary Robert F Kennedy Jr would would potentially link autism to use of the medication in pregnancy.

Kenvue shares fell 14% before recovering slightly to end Friday trading down 9.5% as the firm spoke out to defend its over-the-counter drug.

The company has faced lawsuits for years alleging a possible link between autism and use of Tylenol, which is known as paracetamol in the UK.

The US Department of Health and Human Services said claims about the contents of its much-anticipated autism report were speculation.

According to the Wall Street Journal, Kennedy is expected to issue the findings this month, citing Tylenol use while pregnant as a potential cause of autism.

The newspaper said the federal report is expected to recommend a specific type…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...